Vertex Pharmaceuticals Incorporated (FRA:VX1)
336.80
+1.20 (0.36%)
Last updated: Sep 9, 2025, 9:00 AM CET
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €86.74 billion as of September 10, 2025. Its market cap has decreased by -23.05% in one year.
Market Cap
86.74B
Enterprise Value
77.78B
Revenue
9.72B
Ranking
n/a
PE Ratio
28.00
Stock Price
€336.80
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 86.74B, an increase of 117,302.82%. That is a compound annual growth rate of 22.99%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 8, 2025 | 86.25B | -13.90% |
Dec 31, 2024 | 100.17B | 5.60% |
Dec 29, 2023 | 94.86B | 36.76% |
Dec 30, 2022 | 69.36B | 41.28% |
Dec 31, 2021 | 49.09B | -2.28% |
Dec 31, 2020 | 50.24B | 0.14% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 268.38B |
Siemens Aktiengesellschaft | 179.08B |
Deutsche Telekom AG | 147.97B |
Allianz SE | 134.37B |
Rheinmetall AG | 82.06B |
Siemens Energy AG | 70.72B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.73B |
Deutsche Bank Aktiengesellschaft | 57.56B |